LMR Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
LMR Partners's PFE Position: Q3 2026 in Review
LMR Partners sold out of Pfizer (PFE) in Q3 2026, closing a stake of 260,990 shares — an estimated $6.94M sold.
LMR Partners first reported a position in PFE in Q4 2015 and held it in 18 quarters. The position peaked at $16.9M in Q4 2024. 2,908 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- LMR Partners reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
- LMR Partners sold 260,990 Pfizer shares in Q3 2026, an estimated $6.94M.
- LMR Partners first reported a position in Pfizer in Q4 2015 and held it in 18 quarters.
- LMR Partners's Pfizer position peaked at $16.9M in Q4 2024.
- 2,908 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.